Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2017 Q1- Text added to 2017 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Good
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Good
|
New words:
answer, antitrust, Bayview, BESP, broker, clearance, deliverable, denied, elicit, eligible, Genome, GSK, heard, inactivated, infection, Japanese, lease, linked, Live, methodology, model, optimize, Pasteur, policy, publicly, quote, Sanofi, satisfaction, SE, tied, unethical, upfront, Valneva, waiting, ZIKV
Valuein 2017 Q1 filing- Value in 2017 Q2 filing
Original filings
Filing view